These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 18353459

  • 1. The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia.
    Pitsavos C, Skoumas I, Tousoulis D, Metalinos G, Masoura C, Chrysohoou C, Papadimitriou L, Giotsas N, Toutouza M, Antoniades C, Stefanadis C.
    Int J Cardiol; 2009 May 15; 134(2):280-1. PubMed ID: 18353459
    [Abstract] [Full Text] [Related]

  • 2. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
    Pearson TA, Ballantyne CM, Veltri E, Shah A, Bird S, Lin J, Rosenberg E, Tershakovec AM.
    Am J Cardiol; 2009 Feb 01; 103(3):369-74. PubMed ID: 19166691
    [Abstract] [Full Text] [Related]

  • 3. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan 01; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 4. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
    Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E, Ezetimibe Study Group.
    J Womens Health (Larchmt); 2004 Dec 01; 13(10):1101-7. PubMed ID: 15650343
    [Abstract] [Full Text] [Related]

  • 5. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin.
    Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP.
    Curr Med Res Opin; 2007 Sep 01; 23(9):2183-92. PubMed ID: 17692154
    [Abstract] [Full Text] [Related]

  • 6. Lipid-altering efficacy of the ezetimibe/simvastatin single tablet versus rosuvastatin in hypercholesterolemic patients.
    Catapano AL, Davidson MH, Ballantyne CM, Brady WE, Gazzara RA, Tomassini JE, Tershakovec AM.
    Curr Med Res Opin; 2006 Oct 01; 22(10):2041-53. PubMed ID: 17022864
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
    Brudi P, Reckless JP, Henry DP, Pomykaj T, Lim ST, Massaad R, Vandormael K, Johnson-Levonas AO.
    Cardiology; 2009 Oct 01; 113(2):89-97. PubMed ID: 19018143
    [Abstract] [Full Text] [Related]

  • 8. Usefulness of statin-ezetimibe combination to reduce the care gap in dyslipidemia management in patients with a high risk of atherosclerotic disease.
    Teoh H, Mendelsohn AA, Goodman SG, Jaffer S, Chen RY, Tjia S, Theriault L, Langer A, Leiter LA, Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE) Investigators.
    Am J Cardiol; 2009 Sep 15; 104(6):798-804. PubMed ID: 19733714
    [Abstract] [Full Text] [Related]

  • 9. Lipid-altering efficacy of ezetimibe/simvastatin 10/40 mg compared with doubling the statin dose in patients admitted to the hospital for a recent coronary event: the INFORCE study.
    Reckless JP, Henry P, Pomykaj T, Lim ST, Massaad R, Vandormael K, Johnson-Levonas AO, Lis K, Brudi P, Allen C.
    Int J Clin Pract; 2008 Apr 15; 62(4):539-54. PubMed ID: 18266852
    [Abstract] [Full Text] [Related]

  • 10. Reduction in estimated risk for coronary artery disease after use of ezetimibe with a statin.
    Sampalis JS, Bissonnette S, Habib R, Boukas S, Ezetrol Add-On Investigators.
    Ann Pharmacother; 2007 Sep 15; 41(9):1345-51. PubMed ID: 17666579
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study.
    Roeters van Lennep HW, Liem AH, Dunselman PH, Dallinga-Thie GM, Zwinderman AH, Jukema JW.
    Curr Med Res Opin; 2008 Mar 15; 24(3):685-94. PubMed ID: 18226326
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of ezetimibe in patients with statin-resistant and statin-intolerant familial hyperlipidaemias.
    Wierzbicki AS, Doherty E, Lumb PJ, Chik G, Crook MA.
    Curr Med Res Opin; 2005 Mar 15; 21(3):333-8. PubMed ID: 15811200
    [Abstract] [Full Text] [Related]

  • 13. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
    Ballantyne CM, Abate N, Yuan Z, King TR, Palmisano J.
    Am Heart J; 2005 Mar 15; 149(3):464-73. PubMed ID: 15864235
    [Abstract] [Full Text] [Related]

  • 14. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
    Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, Schultheiss HP, Rauch U.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1035-42. PubMed ID: 17349882
    [Abstract] [Full Text] [Related]

  • 15. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
    Abel T, Fehér J, Dinya E, Eldin MG, Kovács A.
    Med Sci Monit; 2009 Dec 13; 15(12):MS6-11. PubMed ID: 19946244
    [Abstract] [Full Text] [Related]

  • 16. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia.
    Almutairi F, Peterson TC, Molinari M, Walsh MJ, Alwayn I, Peltekian KM.
    Liver Transpl; 2009 May 13; 15(5):504-8. PubMed ID: 19399742
    [Abstract] [Full Text] [Related]

  • 17. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques.
    Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T.
    Clin Ther; 2007 Nov 13; 29(11):2419-32. PubMed ID: 18158082
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).
    Ballantyne CM, Weiss R, Moccetti T, Vogt A, Eber B, Sosef F, Duffield E, EXPLORER Study Investigators.
    Am J Cardiol; 2007 Mar 01; 99(5):673-80. PubMed ID: 17317370
    [Abstract] [Full Text] [Related]

  • 19. [Dual inhibition of cholesterol using the drug combination ezetimibe/simvastatin?].
    Vaverková H.
    Vnitr Lek; 2007 Apr 01; 53(4):421-7. PubMed ID: 17578178
    [Abstract] [Full Text] [Related]

  • 20. Ezetimibe effectively lowers LDL-cholesterol in cardiac allograft recipients on stable statin therapy.
    Konstandin MH, Blessing E, Doesch A, Ammon K, Koch A, Wabnitz GH, Gleissner CA, Remppis A, Katus HA, Dengler TJ.
    Clin Transplant; 2008 Apr 01; 22(5):639-44. PubMed ID: 18492070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.